论文部分内容阅读
环孢霉素Ａ(ＣｓＡ)问世以来显著地提高了肾移植的存活率,但ＣｓＡ的肝肾毒性发生率占10%～50%[1]。一旦处理不当,就会影响移植肾的长期存活,本科对20例ＣｓＡ肝肾毒性患者改用普乐可复(ＦＫ506)治疗收到较好的效果,现报告如下。1 对象和方法1.1 临床资料 本组20例,男13例,?
Since the advent of cyclosporine A (CsA) significantly increased renal transplant survival, but the incidence of liver and kidney toxicity CsA accounted for 10% to 50% [1]. Once properly handled, it will affect the long-term survival of renal allografts, undergraduate 20 cases of CsA liver and kidney toxicity to switch to dipyrone (FK506) received better results, are as follows. 1 objects and methods 1.1 Clinical data The group of 20 patients, 13 males,?